parallel randomized trial

S003052

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Overweight or obesity without diabetes (adults)S003052

Design

Randomized: 88
Start year
Treatment: 14 weeks, follow-up 14 weeks
Countries
Sponsor: (not reported)
Eligibility: adults with obesity and prediabetes

Conduct and analysis

Blinding: double blind
Sequence generation: not reported
Allocation concealment: not reported
Outcome adjudication: not reported
Primary estimand: not stated
Analysis population
Missing data

Arms

Arm	Treatment	Background
A1	liraglutide Liraglutide	lifestyle: not reported
A2	Sitagliptin Sitagliptin	lifestyle: not reported
A3	Lifestyle intervention (randomized arm) Hypocaloric diet	lifestyle: intensive

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.

Characteristic	Statistic	Whole trial ALL
age	mean (years)	50
black	percent	13
other male	percent	32